TLR7 and atherosclerosis: It is unclear if this can really explain the beneficial outcome of TLR7 signalling, since bone marrow chimeras for IFN-β exhibit reduced atherosclerosis [79], indicating that other downstream mechanisms could modulate the beneficial effect of TLR7.